Pioneering Dermal Papilla Hair Growth Technology

The Future of Hair Restoration is Here

ReGrowth Biotech has developed the world's first successful method for regenerating hair follicles using patients' own cells. Our proprietary D.P.G. (Dermal Papilla Growth) technology harnesses the natural regenerative potential of dermal papilla cells—the master controllers of hair follicle development—to create entirely new follicular structures where none existed.

Our technology has demonstrated remarkable effectiveness in real-world applications, including cases where conventional treatments had completely failed. Patients have experienced significant hair regeneration in areas with longstanding hair loss, achieving substantial coverage and density improvements.

How D.P.G. Technology Transforms Hair Restoration

Our revolutionary approach delivers what conventional treatments cannot: true regeneration rather than temporary stimulation or redistribution. The sophisticated cellular process works through precisely controlled stages.

Minimally Invasive Collection

Using just 20 healthy hair follicles extracted in a comfortable 20-minute procedure under local anaesthesia, we begin the regenerative process with minimal patient impact

Advanced Cellular Processing

Our proprietary laboratory techniques expand these cells using the highest-efficiency culture platform available, achieving exceptional cell growth whilst maintaining superior viability standards

Precision Reintroduction

The processed cells are strategically reintroduced to treatment areas, where they activate dormant follicles and generate entirely new follicular structures through natural biological processes

Permanent Regeneration

Unlike medications requiring ongoing application or treatments needing regular sessions, D.P.G. technology provides lasting restoration through biological regeneration that integrates naturally

Advanced Technology Platform

Our proprietary cellular processing system represents a breakthrough in regenerative medicine capabilities, achieving exceptional cell growth rates whilst maintaining the highest viability standards to ensure optimal therapeutic potential. Advanced protocols deliver reliable results with minimal variation, providing predictable outcomes for patients and healthcare partners across all treatment applications.

The efficiency of our platform means that just 20 hair follicles provide sufficient cellular material for comprehensive treatment, maximising patient comfort whilst delivering extensive restoration potential. Our global laboratory network ensures consistent quality and accessibility across international markets, with scalable infrastructure supporting healthcare partners worldwide through standardised protocols and continuous quality assurance.

"After two decades in biotechnology, I've seen many promising treatments, but D.P.G. technology represents something fundamentally different. We're not just slowing hair loss or moving existing hair—we're actually regenerating new follicles using the patient's own cells. When someone who hasn't had hair growth for years suddenly sees new follicles developing, that's not just a medical outcome, that's restored confidence and hope."

— Benno Jiao, MBA, CEO & Founder

Treatment Applications and Flexibility

D.P.G. technology addresses diverse hair restoration needs through flexible application approaches tailored to individual patient requirements. Comprehensive restoration serves as standalone treatment for patients seeking natural hair regeneration without surgical intervention, whilst preventive banking preserves healthy follicular cells before age-related changes occur, providing valuable future therapeutic options.

Enhancement protocols offer potential combination with conventional approaches to improve outcomes and extend treatment possibilities, allowing healthcare providers to develop customised solutions that address individual patient needs, specific hair loss patterns, and personalised restoration goals. This flexibility ensures that D.P.G. technology can adapt to varying clinical scenarios whilst maintaining consistently superior outcomes.